Alerzip-M

Product Composition

Each film-coated tablet contains:

• Montelukast Sodium IP: Equivalent to Montelukast 10 mg.

• Levocetirizine Hydrochloride IP: 5 mg.

• Color: Titanium Dioxide IP.

Product Summary

Alerzip-M is a combination antiallergic medication marketed by Healthgate. It combines an antihistamine (Levocetirizine) with a leukotriene receptor antagonist (Montelukast) to provide comprehensive relief from allergic symptoms. This combination is frequently prescribed for seasonal allergic rhinitis, hay fever, and chronic skin allergies (urticaria) to reduce nasal congestion, sneezing, and itching.

Pros and Cons

Pros

• Dual Mechanism: Targets two different pathways of the allergic response for more effective symptom control.

• Convenience: Provides the benefits of two medications in a single daily tablet.

• 24-Hour Relief: Designed to manage symptoms throughout the day and night with a single dose.

Cons

• Drowsiness Risk: Although Levocetirizine is a later-generation antihistamine, it may still cause mild sleepiness in some users.

• Side Effects: Common reactions may include dry mouth, fatigue, headache, or mild abdominal pain.

• Specific Monitoring: Montelukast has been associated with mood-related changes in a small number of patients.

How to Use

• Administration: Swallow the tablet whole with a glass of water. Do not crush or chew it.

• Timing: It can be taken with or without food. It is often recommended to take it in the evening to best manage nighttime and early morning symptoms.

• Dosage: Use strictly as directed by the Physician.

• Storage: Store protected from light and moisture at a temperature not exceeding 30°C. Keep all medicines out of reach of children.

Warning: This is a Schedule H Prescription Drug and should be used only under the guidance and prescription of a Registered Medical Practitioner.